Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Jul-Aug;21(7-8):798-807.
doi: 10.1016/j.jpain.2019.11.007. Epub 2019 Nov 21.

Integrated Behavioral Treatment for Veterans With Co-Morbid Chronic Pain and Hazardous Opioid Use: A Randomized Controlled Pilot Trial

Affiliations
Randomized Controlled Trial

Integrated Behavioral Treatment for Veterans With Co-Morbid Chronic Pain and Hazardous Opioid Use: A Randomized Controlled Pilot Trial

Kevin E Vowles et al. J Pain. 2020 Jul-Aug.

Abstract

Opioid prescription in the treatment of chronic pain is frequent and carries a risk of increased morbidity and mortality in a clinically significant number of patients, particularly those who are using opioids in a hazardous manner. Few treatment options are available that target both pain-related interference and hazardous opioid use among patients with chronic pain. In military Veterans, this issue is of particular importance as numerous reports indicate continued high rates of opioid prescription for chronic pain, as well as significant opioid-related problems. The overall aim of the present study was to determine the feasibility of an integrated psychosocial treatment in Veterans with chronic pain, who also have evidence of hazardous opioid use. To examine this aim, a random design was used to assess the feasibility and initial efficacy of integrating 2 empirically supported interventions: Acceptance and Commitment Therapy for chronic pain and Mindfulness Based Relapse Prevention for opioid misuse. Half of participants were randomized to the integrated treatment group and all participants received usual care through a Veteran's Administration co-occurring disorders medical clinic to treat chronic pain and opioid misuse. In total, 37 participants were randomized and included in intent-to-treat analyses and 32 individuals were included in per protocol analyses with 6-month follow-up serving as the primary study endpoint. Feasibility indicators included recruitment, retention, and treatment completion rates. Recruitment fell short of targeted enrollment, although retention and completion were excellent. Primary outcome measures were opioid misuse, pain interference, and pain behavior. Simultaneous multiple regression analyses controlled for pain duration, baseline opioid dose, and baseline value for outcome measures. Results of both the intent-to-treat and per protocol indicated a significant effect in favor of the integrated intervention for opioid misuse, pain interference, and pain behavior. Results support the feasibility of providing an integrated treatment for both opioid risk and pain interference. PERSPECTIVE: Opioid misuse occurs in some opioid-prescribed individuals with chronic pain. Few treatment options exist that target both pain interference and opioid misuse. This study examined feasibility and initial efficacy of an integrated behavioral treatment for Veterans. Feasibility was supported, except recruitment. Efficacy was supported compared to usual care.

Keywords: Chronic pain; acceptance and commitment therapy; integrated treatment; mindfulness-based relapse prevention; opioids; veterans.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Participant flow through the study

References

    1. American Psychological Association - Division 12 Society of Clinical Psychology (Institution/Organization): Acceptance and commitment therapy for chronic pain [Internet]. [cited 2018 Apr 3]. Available at: http://www.div12.org/PsychologicalTreatments/treatments/chronicpain_act..... Accessed April 5, 2019
    1. Amtmann D, Cook KF, Jensen MP, Chen W, Choi S, Revicki D, Cella D, Rothrock N, Keefe F, Callahan L, Lai J: Development of a PROMIS item bank to measure pain interference. Pain 150:173–182, 2010 - PMC - PubMed
    1. Bailey RW, Vowles KE: Chronic noncancer pain and opioids: Risks, benefits, and the public health debate. Prof Psychol Res Pract 46:340–347, 2015
    1. Ballantyne JC, Fleisher LA: Ethical issues in opioid prescribing for chronic pain. Pain 148:365–367, 2010. Accessed April 5, 2019 - PubMed
    1. Barry DT, Beitel M, Cutter CJ, Fiellin DA, Kerns RD, Moore BA, Oberleitner L, Madden LM, Liong C, Ginn J, Schottenfeld RS: An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain. Drug Alcohol Depend 194:460–467, 2019 - PMC - PubMed

Publication types